Ignite Creation Date:
2024-05-06 @ 12:57 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03896945
Status:
TERMINATED
Last Update Posted:
2024-05-24
First Post:
2019-03-19
Brief Title:
Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-19
First Submit QC Date:
March 28 2019
Study First Post Date:
2019-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2024-05-21
Disp First Submit QC Date:
None
Disp First Post Date:
2023-12-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-05-21
Last Update Post Date:
2024-05-24
Last Update Post Date Type:
ACTUAL